Urinary Incontinence, Stress Clinical Trial
Official title:
A Randomised, Single-Blind Comparison of Pelvic Floor Muscle Exercises With Biofeedback Versus Weighted Vaginal Cones in the Management of Genuine Stress Incontinence : A Pilot Study
The purpose of this study is to determine the objective (urodynamic) cure rates and effect
on patient quality of life after six months of treatment for two different nonsurgical
management options for genuine stress urinary incontinence in females: weighted vaginal
cones and formal supervised pelvic floor physiotherapy with biofeedback.
Hypothesis: Assuming a minimum of six months of treatment, weighted vaginal cones are as
effective as a formal supervised program of pelvic floor physiotherapy with biofeedback for
the treatment of uncomplicated genuine stress urinary incontinence in females.
Background and Rationale Urinary incontinence is a widespread and debilitating medical
problem, with an estimated prevalence of between 17-45% in adult women. Genuine stress
incontinence is the most common form of urinary incontinence in women, with objective
diagnosis made via urodynamics. Urinary continence is maintained when the urethral
resistance (pressure) is greater than the intravesical pressure. Genuine stress incontinence
occurs when pressure transmission to the urethra is compromised by poor anatomic support of
the proximal urethra resulting from weakened pelvic floor musculature and/or defective
endopelvic fascia. While the gold standard for treatment of genuine stress incontinence is
still considered to be surgical, there is renewed interest among both patients and surgeons
for nonsurgical (conservative) management. The goal of conservative therapy is to
restrengthen and retrain the pelvic floor muscles to improve urethral pressure transmission
and thus improve the continence mechanism.
Nonsurgical therapies include PFME with or without biofeedback, and weighted vaginal cones.
PFME with biofeedback are widely accepted as an effective conservative treatment for genuine
stress incontinence, with subjective cure rates estimated to be as high as 70 percent.
However, to date, objective cure rates as defined by urodynamics have not been well
documented. Similarly, while limited studies suggest that vaginal cone therapy results in a
subjective cure rate of 60%, objective cure rates still have not been determined. With
growing clinic and surgical waiting lists and rising hospital costs, weighted vaginal cones,
if objectively proven to be a comparably effective alternative to physiotherapy, will offer
an effective management option for stress incontinence, thus, perhaps avoiding referral to a
tertiary hospital for physiotherapy, and surgery.
We hypothesize that following a minimum of six months of treatment, weighted vaginal cones
would be as effective as a formal supervised program of pelvic floor physiotherapy with
biofeedback for the treatment of uncomplicated genuine stress urinary incontinence in
females. We are thus seeking to evaluate the feasibility of a randomized clinical trial.
Method
An estimated 60 women identified from ambulatory clinics with multichannel urodynamics
documenting genuine stress urinary incontinence will be needed to participate in this
single-blind, randomized pilot study. Once entered, patients will be randomized to receive
one of two different nonsurgical treatments: PFME with biofeedback or weighted vaginal
cones. The patients will chart compliance to treatment for the duration of the study. A
quality of life questionnaire will be completed at the beginning and end of the trial, along
with a subjective assessment of incontinence severity via a standardized questionnaire. The
study period will be six months. Upon completion of the study, patients will undergo repeat
multichannel urodynamics and perineal pad testing to determine if genuine stress
incontinence is present or absent and thus whether objective cure has been achieved. Results
will be analyzed and compared statistically.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02001714 -
Group Learning Achieves Decreased Incidents of Lower Urinary Symptoms
|
N/A | |
Not yet recruiting |
NCT00523068 -
Pharmacological vs Surgical Treatment for Mixed Incontinence
|
Phase 4 | |
Completed |
NCT00904969 -
A Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
|
N/A | |
Completed |
NCT00190814 -
Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge.
|
Phase 3 | |
Completed |
NCT00190827 -
Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Uncontrolled Leakage of Urine)
|
Phase 3 | |
Completed |
NCT01959347 -
Combined Treatment for Mixed Incontinence
|
Phase 3 | |
Completed |
NCT00244296 -
To Determine How Effective Duloxetine is in Treating Women 65 Years and Older With Symptoms of Stress Urinary Incontinence, or With a Combination of Stress Urinary Incontinence and Urge Urinary Incontinence Symptoms
|
Phase 4 | |
Not yet recruiting |
NCT05570071 -
A Study of the Use of Vaginal Radiofrequency Therapy in Treatment of SUI.
|
N/A | |
Completed |
NCT02334878 -
Stem Cell Therapy for Treatment of Female Stress Urinary Incontinence
|
Phase 3 | |
Completed |
NCT01382602 -
Autologous Muscle Derived Cells Female Stress Urinary Incontinence Clinical Study
|
Phase 3 | |
Completed |
NCT03296462 -
Hip External Rotation Physical Therapy Trial
|
N/A | |
Recruiting |
NCT02750878 -
Surgical Consent Process for Trans-obturator Tape Slings.
|
N/A | |
Completed |
NCT02296099 -
Trial Liposomal Bupivacaine Following Retropubic Suburethral Sling for Stress Urinary Incontinence
|
Phase 4 | |
Completed |
NCT02599051 -
Transobturator Verus Single Incision Slings
|
N/A | |
Completed |
NCT00138749 -
An 8 Week Study Looking At The Efficacy, Toleration And Safety Of SS-RBX For Stress Urinary Incontinence.
|
Phase 2 | |
Terminated |
NCT03614611 -
Canadian Experience With Contiform Intravaginal Device For The Treatment Of Stress Incontinence
|
N/A | |
Completed |
NCT03722719 -
The Knack on Female Stress Urinary Incontinence
|
N/A | |
Active, not recruiting |
NCT02275728 -
Pelvic Floor Muscle Training With and Without Biofeedback in Women With Stress Urinary Incontinence
|
N/A | |
Terminated |
NCT01358214 -
Quality of Life After Tension Free Transvaginal Sling / Tape Operation With a Titanized Surgical Tape (TiLOOP® Tape)
|
N/A | |
Active, not recruiting |
NCT01323426 -
Treatment of Stress Urinary Incontinence by Injection of Autologous Muscle Fibers Into the Urethral Sphincter.
|
Phase 1/Phase 2 |